NEXUS BIOPHARMA INC: key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2016)
- -$686.1K
- Total Assets (FY2016)
- $9.5K
- Total Equity (FY2016)
- -$1.5M
- Cash Flows from Operating Activities (FY2016)
- -$492.4K
Source: NEXUS BIOPHARMA INC 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
